Current Report Filing (8-k)
July 11 2019 - 7:00AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 11,
2019
KRAIG BIOCRAFT LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Wyoming
|
|
|
|
83-0458707
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
2723
South State St. Suite 150
Ann Arbor, Michigan 48104
(Address of principal executive offices, including Zip
Code)
(734) 619-8066
(Registrant’s telephone number, including area
code)
Not Applicable
(Former name or former address, if changed since last
report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange on which registered
|
None
|
|
-
|
|
-
|
Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (?230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging
growth company
☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.
☐
Item 7.01: Regulation FD Disclosure
On or about July 13, 2019, Kraig Biocraft Laboratories, Inc. (the
“Company”) will complete the mailings of notice to its
shareholders regarding the Company’s upcoming annual
shareholder meeting. The shareholder meeting will
be held at
10:00 a.m., eastern standard time, at East Lansing Marriott at
University Place, 300 M. A. C. Ave, East Lansing, MI 48823, on July
24, 2019, for the purpose of considering and voting upon
several proposals, as set forth in the notice, which is attached
hereto as Exhibit 99.1
The notice and related proxy card will be mailed to
each shareholder
entitled to vote at the annual meeting. Shareholders are urged to
read the entire notice as it contains important information about
the proposed corporate actions.
After
the annual meeting, we will file an amendment to this Report to
disclose the voting results.
The information included in Item 7.01 is intended to be furnished
and shall not be deemed “filed” for purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by
reference in any filing under the
Securities Act of
1933
, as amended (the
“Securities Act”), or the
Exchange
Act
, except as expressly set
forth by specific reference in such filing.
On July
8, 2019, the Company issued a press release announcing the annual
shareholder meeting and related information. A copy of the press
release is filed as Exhibit 99.2 to this Current Report on
Form 8-K and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
Exhibit
No.
|
Description
|
99.1
|
Notice
to Shareholders
|
99.2
|
Press
Release
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date:
July 11, 2019
|
KRAIG BIOCRAFT LABORATORIES, INC.
|
|
|
|
|
By:
|
/s/ Kim
Thompson
|
|
|
Kim
Thompson
|
|
|
Chief
Executive Officer, Chief Financial Officer and
Director
|
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Apr 2023 to Apr 2024